Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
    Published on 2025-12-14
    8 months ago
  • An adolescent hangover: astrocyte dysfunction in paraventricular thalamus promotes adult anxiety after alcohol exposure in adolescent mice
    Published on 2025-12-12
    8 months ago
  • Acute stress induces changes in epigenome-wide DNA methylation
    Published on 2025-12-11
    8 months ago
  • Aberrant effective connectivity during working memory performance in schizotypal personality disorder and schizophrenia: A spectrum approach
    Published on 2025-12-10
    8 months ago
  • Corticosterone accelerates behavioral inflexibility via plasticity-related gene expression in the dorsal striatum
    Published on 2025-12-08
    8 months ago
  • ENX-104: a selective and potent D2/D3 receptor antagonist enhances dopamine neurotransmission and reward responsiveness in translational rodent models
    Published on 2025-12-06
    8 months ago
  • Getting into the weed—the genetics of cannabis use in modern America
    Published on 2025-12-01
    8 months ago
« Previous 1 … 30 31 32 33 34 … 143 Next »
Journal of Psychopharmacology
  • Circadian rhythmicity in prepulse inhibition of the acoustic startle response: A study of chronotype and time-of-day effects in young healthy adults
    Published on 2025-05-15
    1 year ago
  • CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations
    Published on 2025-05-12
    1 year ago
  • Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
    Published on 2025-05-12
    1 year ago
  • The effects of menthol content on the abuse liability of smokeless tobacco in a randomized crossover trial
    Published on 2025-05-08
    1 year ago
  • Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
    Published on 2025-05-06
    1 year ago
  • Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?
    Published on 2025-05-05
    1 year ago
  • Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
    Published on 2025-05-05
    1 year ago
« Previous 1 … 30 31 32 33 34 … 150 Next »
European Neuropsychopharmacology
  • Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale
    Published on 2025-02-27
    1 year ago
  • The role of esketamine in persistent long COVID with predominant psychiatric manifestations
    Published on 2025-02-27
    1 year ago
  • The cumulative production and conjugation of steroid hormones during pregnancy predict postpartum depressive mood
    Published on 2025-02-22
    1 year ago
  • Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysis
    Published on 2025-02-21
    1 year ago
  • “Much ado about nothing?” advocating for neuroscientific research in maternal perfectionism and perinatal mental health disorders
    Published on 2025-02-17
    1 year ago
  • On the potential of xanomeline-trospium chloride for schizophrenia and beyond
    Published on 2025-02-17
    1 year ago
  • Letter to the editor concerning: “Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis”
    Published on 2025-02-16
    1 year ago
« Previous 1 … 30 31 32 33 34 … 168 Next »

   Pharma Pub